National service at the Military Hospital Innsbruck
1989 - 1996
Postdoc, Department of Pharmacology and Toxicology, University of Innsbruck
1996
Habilitation "In vivo release of endogenous monoamine- and amino acid neurotransmitters in medullary and supramedullary brain areas"
1996
Associate Professor for Pharmacology and Toxicology
1998 - 1999
Schroedinger Fellowship at the University of Oxford, UK, Department of Clinical Pharmacology, Prof. Grahame-Smith, Dr. Trevor Sharp
1999 - 2001
Interimistic head of the Department of Pharmacology and Toxicology, University of Innsbruck
2002
Head of Neuropharmacology unit at the Department of Pharmacology and Toxicology, LFU Innsbruck
Teaching Experience
1991 - 2003
Pharmacology, Toxicology and Bromatology (Lectures and courses) Computer-supported Lecture in Pharmacology Methods and Techniques in Pharmacological Science (Lecture and courses)
1999 - 2001
"Pharmacology" (main course)
since 2000
Stem Cells and Gene Therapy (Lecture) Molecular and pharmacological analytics (course) Selected chapters in Pharmacology: Neuropharmacology (Main lecture) General Pharmacology (Course)
since 2003
Postgraduate course: "Behavioural models in Neuroscience"
since 2011
Anatomy, Physiology & Pathophysiology, Research Techniques (Lecture)
since 2018
Medication Therapy and Clinical Pharmacy (Lecture) Patient-oriented Aspects of Medication Therapy (Lecture and course)
Recent Grant Support
Neurobiology of anxiety in autism spectrum disorders (FWF FG 2022-2026)
Role of microglial/myeloid system in inborn anxiety and comorbid depression (FWF 2019-2024)
Doctoral Programme W1206 " Signal processing in Neurons” (FWF 2017 – 2021)
Dopamine-ghrelin interactions as novel Targets for Treatment-resistant anxiety (FWO/FWF, 2016-2020)
Epigenetic mechanisms in aberrant memory regulation (FWF SFB44 2015-19)
Patents
Europ. Pat. Nr. 87106381.4: Klötzer W, Link H, Müssner R, Schiestl W, Singewald N: 1.3-Disubstituierte Imidazoliumsalze
Europ. Pat. Nr. 88103746.9: Klötzer W, Montavon M, Müssner R, Singewald N: Benzyliden-amino-, benzylamino und benzoylamino-imidazolderivate
